Jeong-ok N. Lee
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications
Asciminib as first-line therapy in chronic myeloid leukemia: a systematic review.
Journal: Blood research
Published: March 23, 2026
Phase II study of lenalidomide maintenance after rituximab-methotrexatebased induction therapy in primary central nervous system lymphoma.
Journal: Haematologica
Published: February 24, 2026
Risks of anticoagulation discontinuation after first venous thromboembolism in inherited thrombophilia: a long-term cohort study.
Journal: Research and practice in thrombosis and haemostasis
Published: February 19, 2026
Distinct immunophenotypic and clinical features of TP53-mutated acute myeloid leukemia: high CD34/CD41 expression and lower leukocyte counts.
Journal: Annals of hematology
Published: December 26, 2025
Thrombosis in adult primary immune thrombocytopenia in Korea: incidence and risk factors in a 20-year retrospective cohort.
Journal: Annals of hematology
Published: December 02, 2025
Clinicopathological spectrum of CD10, BCL6, MUM1 triple-positive diffuse large B-cell lymphoma and large B-cell lymphoma with IRF4 rearrangement.
Journal: Histopathology
Published: November 06, 2025
Comparative Outcomes of Consolidation Strategies After R-MVP Induction in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
Journal: Cancer medicine
Published: October 31, 2025
Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry.
Journal: Blood cancer journal
Published: October 31, 2025
Comparison of Thiotepa, Busulfan, and Cyclophosphamide Versus Busulfan and Thiotepa Conditioning Regimens in Autologous Stem Cell Transplantation for Primary CNS Lymphoma: A Multicenter Retrospective Analysis.
Journal: Hematological oncology
Published: October 28, 2025
Prognostic impact of GNRI-IPI score in octogenarians with diffuse large B-Cell lymphoma treated with R-CHOP.
Journal: Annals of hematology
Published: August 12, 2025
Impact of Cell-of-Origin and MYC/BCL2 Status on the Risk of Central Nervous System Relapse in Primary Breast Diffuse Large B-Cell Lymphoma.
Journal: Cancer research and treatment
Published: August 05, 2025
Last Updated: 09/26/2026